Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Completion of the demerger of Haleon and share consolidation of GSK
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Manish led SeQuent since 2014 and played a major role in transforming the company
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
